Earnings Optimism Puts Wind in Wall Street's Sails

Nike's upbeat earnings are easing some recent recession anxieties

Digital Content Manager
Dec 21, 2022 at 12:19 PM
facebook twitter linkedin

The major indexes are extending their rally off a mid-December losing streak, as upbeat earnings from Nike (NKE) and FedEx (FDX) provided some assurance to investors that upcoming corporate earnings may not be as bad as initially feared. On the data front, existing home sales dropped 7.7% for November, which was lower than the 5.9% drop expected. On the other hand, however, the consumer confidence index rose to a better-than-expected 108.3 for December. In response, the Dow Jones Industrial Average (DJI) is up more than 500 points, while the S&P 500 Index (SPX) and Nasdaq Composite Index (IXIC) both sport midday gains of more than 1%. 

Continue reading for more on today's market, including: 

new midday stats dec 21

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) is seeing an uptick in put activity as it continues to build on this week's more than 260% surge, following an upbeat study on its nonalcoholic steatohepatitis (NASH) drug. The security was last seen up 11% at $277.50, trading at its highest level since July 2018. Circling back to options activity, 3,777 puts have been exchanged so far, which is double the intraday average, compared to 1,998 calls. The most popular position is the January 2023 120-strike put, followed by the July 2023 250-strike put, with positions being bought to open at the latter. 

SINTX Technologies Inc (NASDAQ:SINT) is one of the best performing stocks on the Nasdaq today, last seen up 73.8% at $12.91, following news that it received a $150,000 contract from a section of the U.S. Department of Defense. SINT is trading back above recent pressure at the 50-day moving average, though the $16 mark is working as a ceiling for the equity, keeping it at a 79.9% year-to-date deficit. 

SINT dec 21

One of the worst performers on the Nasdaq is Lipella Pharmaceuticals Ord Shs (NASDAQ:LIPO). The equity was last seen down 23.3% at $3.61. The biotech stock went public yesterday, trading as high as $7.72 before settling at $4.71. 


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners